---
figid: PMC4747886__jcav07p0314g004
figtitle: Molecular mechanisms of survivin in tumorigenesis
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
pmcid: PMC4747886
filename: jcav07p0314g004.jpg
figlink: /pmc/articles/PMC4747886/figure/F4/
number: F4
caption: Molecular mechanisms of survivin in tumorigenesis. (A) Survivin binds and
  suppresses effector caspases (caspase-3 and 7) and caspase-9, thereby resulting
  in decreased apoptosis in cancer cells. (B) CDC2 can directly phosphorylate survivin.
  Survivin also interacts with CDK4, which results in nuclear translocation, thereby
  leading to S phase shift. (C) Wild-type p53 represses survivin expression at the
  transcriptional level. (D) Activation of the Wnt signaling pathway leads to accumulation
  of β-catenin in the cytoplasm, which then translocates to the nucleus to form the
  β-catenin/TCF enhancer factor transcriptional machinery and upregulate survivin.
  (E) Both HIF-1α and STAT3 can directly bind to the survivin promoter and function
  as transcriptional activators of the survivin gene. (F) TGF-β is a negative regulator
  of survivin. The TGF signaling pathway transcriptionally downregulates survivin
  expression through a mechanism dependent on Smads 2, 3, and 4.
papertitle: 'Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.'
reftext: Xun Chen, et al. J Cancer. 2016;7(3):314-323.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9552836
figid_alias: PMC4747886__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC4747886__F4
ndex: a6532091-deaf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4747886__jcav07p0314g004.html
  '@type': Dataset
  description: Molecular mechanisms of survivin in tumorigenesis. (A) Survivin binds
    and suppresses effector caspases (caspase-3 and 7) and caspase-9, thereby resulting
    in decreased apoptosis in cancer cells. (B) CDC2 can directly phosphorylate survivin.
    Survivin also interacts with CDK4, which results in nuclear translocation, thereby
    leading to S phase shift. (C) Wild-type p53 represses survivin expression at the
    transcriptional level. (D) Activation of the Wnt signaling pathway leads to accumulation
    of β-catenin in the cytoplasm, which then translocates to the nucleus to form
    the β-catenin/TCF enhancer factor transcriptional machinery and upregulate survivin.
    (E) Both HIF-1α and STAT3 can directly bind to the survivin promoter and function
    as transcriptional activators of the survivin gene. (F) TGF-β is a negative regulator
    of survivin. The TGF signaling pathway transcriptionally downregulates survivin
    expression through a mechanism dependent on Smads 2, 3, and 4.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mdm2
  - Cdk1
  - Cdc2b
  - Ctnnb1
  - Casp9
  - Trp53
  - Cdk4
  - Tgfb1
  - Ltbp1
  - Smad2
  - Smad3
  - Hif1a
  - Smad4
  - Stat3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MDM2
  - CDK1
  - POLD1
  - CTNNB1
  - TP53
  - TP63
  - TP73
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CDK4
  - HNF4A
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD2
  - SMAD3
  - HIF1A
  - SMAD4
  - STAT3
---
